These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
185 related articles for article (PubMed ID: 30075372)
1. Multiple functions of p27 in cell cycle, apoptosis, epigenetic modification and transcriptional regulation for the control of cell growth: A double-edged sword protein. Abbastabar M; Kheyrollah M; Azizian K; Bagherlou N; Tehrani SS; Maniati M; Karimian A DNA Repair (Amst); 2018 Sep; 69():63-72. PubMed ID: 30075372 [TBL] [Abstract][Full Text] [Related]
2. Pim kinases promote cell cycle progression by phosphorylating and down-regulating p27Kip1 at the transcriptional and posttranscriptional levels. Morishita D; Katayama R; Sekimizu K; Tsuruo T; Fujita N Cancer Res; 2008 Jul; 68(13):5076-85. PubMed ID: 18593906 [TBL] [Abstract][Full Text] [Related]
3. Post-translational regulation of the tumor suppressor p27(KIP1). Vervoorts J; Lüscher B Cell Mol Life Sci; 2008 Oct; 65(20):3255-64. PubMed ID: 18636226 [TBL] [Abstract][Full Text] [Related]
4. p27(Kip1) signaling: Transcriptional and post-translational regulation. Hnit SS; Xie C; Yao M; Holst J; Bensoussan A; De Souza P; Li Z; Dong Q Int J Biochem Cell Biol; 2015 Nov; 68():9-14. PubMed ID: 26279144 [TBL] [Abstract][Full Text] [Related]
5. A novel cyclinE/cyclinA-CDK inhibitor targets p27(Kip1) degradation, cell cycle progression and cell survival: implications in cancer therapy. Dai L; Liu Y; Liu J; Wen X; Xu Z; Wang Z; Sun H; Tang S; Maguire AR; Quan J; Zhang H; Ye T Cancer Lett; 2013 Jun; 333(1):103-12. PubMed ID: 23354589 [TBL] [Abstract][Full Text] [Related]
6. BCR signals target p27(Kip1) and cyclin D2 via the PI3-K signalling pathway to mediate cell cycle arrest and apoptosis of WEHI 231 B cells. Banerji L; Glassford J; Lea NC; Thomas NS; Klaus GG; Lam EW Oncogene; 2001 Nov; 20(50):7352-67. PubMed ID: 11704865 [TBL] [Abstract][Full Text] [Related]
7. The Cdk inhibitor p27 in human cancer: prognostic potential and relevance to anticancer therapy. Chu IM; Hengst L; Slingerland JM Nat Rev Cancer; 2008 Apr; 8(4):253-67. PubMed ID: 18354415 [TBL] [Abstract][Full Text] [Related]
8. The cyclin-dependent kinase inhibitor p27 kip1 regulates radial stem cell quiescence and neurogenesis in the adult hippocampus. Andreu Z; Khan MA; González-Gómez P; Negueruela S; Hortigüela R; San Emeterio J; Ferrón SR; Martínez G; Vidal A; Fariñas I; Lie DC; Mira H Stem Cells; 2015 Jan; 33(1):219-29. PubMed ID: 25185890 [TBL] [Abstract][Full Text] [Related]
9. SUMOylation regulates p27Kip1 stability and localization in response to TGFβ. Lovisa S; Citro S; Sonego M; Dall'Acqua A; Ranzuglia V; Berton S; Colombatti A; Belletti B; Chiocca S; Schiappacassi M; Baldassarre G J Mol Cell Biol; 2016 Feb; 8(1):17-30. PubMed ID: 26450989 [TBL] [Abstract][Full Text] [Related]
11. Inducible expression of a degradation-resistant form of p27Kip1 causes growth arrest and apoptosis in breast cancer cells. Zhang Q; Tian L; Mansouri A; Korapati AL; Johnson TJ; Claret FX FEBS Lett; 2005 Jul; 579(18):3932-40. PubMed ID: 15996662 [TBL] [Abstract][Full Text] [Related]
12. CDK inhibitors, p21(Cip1) and p27(Kip1), participate in cell cycle exit of mammalian cardiomyocytes. Tane S; Ikenishi A; Okayama H; Iwamoto N; Nakayama KI; Takeuchi T Biochem Biophys Res Commun; 2014 Jan; 443(3):1105-9. PubMed ID: 24380855 [TBL] [Abstract][Full Text] [Related]
13. COP1 enhances ubiquitin-mediated degradation of p27Kip1 to promote cancer cell growth. Choi HH; Phan L; Chou PC; Su CH; Yeung SC; Chen JS; Lee MH Oncotarget; 2015 Aug; 6(23):19721-34. PubMed ID: 26254224 [TBL] [Abstract][Full Text] [Related]
14. p27 Bencivenga D; Caldarelli I; Stampone E; Mancini FP; Balestrieri ML; Della Ragione F; Borriello A Cancer Lett; 2017 Sep; 403():354-365. PubMed ID: 28687353 [TBL] [Abstract][Full Text] [Related]
15. PI3K/AKT pathway-mediated regulation of p27(Kip1) is associated with cell cycle arrest and apoptosis in cervical cancer. Prasad SB; Yadav SS; Das M; Modi A; Kumari S; Pandey LK; Singh S; Pradhan S; Narayan G Cell Oncol (Dordr); 2015 Jun; 38(3):215-25. PubMed ID: 25821107 [TBL] [Abstract][Full Text] [Related]